Published in Biol Psychiatry on April 15, 2002
Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct (2009) 1.35
Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci (2005) 1.30
Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biol Mood Anxiety Disord (2012) 1.04
Advances in the treatment of depression. NeuroRx (2006) 1.03
Brain stimulation in psychiatry and its effects on cognition. Nat Rev Neurol (2010) 0.98
Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul (2010) 0.96
"Getting physical": the management of neuropsychiatric disorders using novel physical treatments. Neuropsychiatr Dis Treat (2006) 0.92
Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model. Psychol Med (2014) 0.86
Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depress Res Treat (2014) 0.86
Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues Clin Neurosci (2006) 0.82
Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls. World J Psychiatry (2015) 0.81
Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression - an open label trial. Neuropsychiatr Dis Treat (2007) 0.81
Transcranial magnetic stimulation for the treatment of major depression. Neuropsychiatr Dis Treat (2015) 0.80
Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry. Psychiatry (Edgmont) (2006) 0.80
Combination rapid transcranial magnetic stimulation in treatment refractory depression. Neuropsychiatr Dis Treat (2006) 0.80
Transcranial Magnetic Stimulation to Address Mild Cognitive Impairment in the Elderly: A Randomized Controlled Study. Behav Neurol (2015) 0.78
Noninvasive Brain Stimulation in Pediatric Attention-Deficit Hyperactivity Disorder (ADHD): A Review. J Child Neurol (2015) 0.78
Comment on "Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial". Biol Psychiatry (2002) 0.77
Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.77
Treatment of late-life depression: a role of non-invasive brain stimulation techniques. Int Rev Psychiatry (2011) 0.75
Hypomanic shift observed during rTMS treatment of patients with unipolar depressive disorder: four case reports. Ann Gen Psychiatry (2013) 0.75
Transcranial magnetic stimulation: a new tool in the fight against depression. Dialogues Clin Neurosci (2002) 0.75
Repetitive Transcranial Magnetic Stimulation (rTMS)-Induced Trigeminal Autonomic Cephalalgia. Noro Psikiyatr Ars (2015) 0.75
Transcranial Magnetic Stimulation : A New Therapeutic Tool in Psychiatry. Med J Armed Forces India (2011) 0.75
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis. Prim Care Companion CNS Disord (2015) 0.75
The future of antidepressant pharmacotherapy. World Psychiatry (2003) 0.75
A systematic review for the antidepressant effects of sleep deprivation with repetitive transcranial magnetic stimulation. BMC Psychiatry (2015) 0.75
In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature (2011) 4.81
A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry (2005) 4.07
Medial frontal cortex activity and loss-related responses to errors. J Neurosci (2006) 2.15
Optical biosensors for food quality and safety assurance-a review. J Food Sci Technol (2011) 2.11
Genome-wide association studies for agronomical traits in a world wide spring barley collection. BMC Plant Biol (2012) 1.79
Novelty responses and differential effects of order in the amygdala, substantia innominata, and inferior temporal cortex. Neuroimage (2003) 1.59
Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry (2005) 1.59
Neuroimaging studies of emotional responses in PTSD. Ann N Y Acad Sci (2006) 1.51
Failure of positive but not negative emotional valence to enhance memory in schizophrenia. J Abnorm Psychol (2007) 1.43
Amygdala and insular responses to emotionally valenced human faces in small animal specific phobia. Biol Psychiatry (2003) 1.40
Altered amygdala resting-state functional connectivity in post-traumatic stress disorder. Front Psychiatry (2011) 1.39
Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry (2006) 1.37
Chronic disease self-management program for low back pain in the elderly. J Manipulative Physiol Ther (2005) 1.32
Dorsal anterior cingulate function in posttraumatic stress disorder. J Trauma Stress (2007) 1.23
Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr Bull (2008) 1.23
Measurement techniques and application of electrical properties for nondestructive quality evaluation of foods-a review. J Food Sci Technol (2011) 1.21
Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr Res (2006) 1.18
AMG 837: a potent, orally bioavailable GPR40 agonist. Bioorg Med Chem Lett (2011) 1.13
Cost-effectiveness of medical and chiropractic care for acute and chronic low back pain. J Manipulative Physiol Ther (2005) 1.12
Robust ZFN-mediated genome editing in adult hemophilic mice. Blood (2013) 1.11
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul (2010) 1.07
A magnetic resonance imaging study of cortical thickness in animal phobia. Biol Psychiatry (2004) 1.05
A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia. Schizophr Res (2009) 1.05
Amygdala responses to human faces in obsessive-compulsive disorder. Biol Psychiatry (2004) 1.04
Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatr Serv (2006) 1.03
Prolonged exposure for PTSD in a Veterans Health Administration PTSD clinic. J Trauma Stress (2009) 1.02
A novel bacterial blight resistance gene from Oryza nivara mapped to 38 kb region on chromosome 4L and transferred to Oryza sativa L. Genet Res (Camb) (2008) 1.01
The therapeutic potential of GPR120: a patent review. Expert Opin Ther Pat (2013) 1.01
Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J Psychiatry Neurosci (2009) 0.99
Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry (2011) 0.95
Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol (2003) 0.94
Enhanced amygdala responses to emotional versus neutral schematic facial expressions. Neuroreport (2002) 0.94
Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. Cancer Prev Res (Phila) (2011) 0.94
Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery. Compr Psychiatry (2008) 0.94
The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro. J Pineal Res (2008) 0.92
An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia. Psychiatry Res (2009) 0.91
Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Neuropsychopharmacology (2002) 0.90
Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Pharmacotherapy (2009) 0.89
A method of determining the dose of digoxin for heart failure in the modern era. Arch Intern Med (2006) 0.88
Single-dose pharmacokinetic study of lycopene delivered in a well-defined food-based lycopene delivery system (tomato paste-oil mixture) in healthy adult male subjects. Cancer Epidemiol Biomarkers Prev (2004) 0.88
Mechanisms of early trauma-induced coagulopathy: The clot thickens or not? J Trauma Acute Care Surg (2015) 0.88
Neurocognition in schizophrenia: a 20-year multi-follow-up of the course of processing speed and stored knowledge. Compr Psychiatry (2010) 0.88
Brain correlates of negative and positive visuospatial priming in adults. Neuroimage (2005) 0.88
Evidence for reduced cerebellar volumes in trichotillomania. Biol Psychiatry (2006) 0.85
Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops. Mol Nutr Food Res (2014) 0.85
Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with progressive renal dysfunction. J Gastroenterol Hepatol (2009) 0.84
Discovery of genes affecting resistance of barley to adapted and non-adapted powdery mildew fungi. Genome Biol (2014) 0.83
Substituted pyrazoles as novel sEH antagonist: investigation of key binding interactions within the catalytic domain. Bioorg Med Chem Lett (2010) 0.82
VA healthcare costs of a collaborative intervention for chronic pain in primary care. Med Care (2010) 0.82
Exogenous glucocorticoids decrease subgenual cingulate activity evoked by sadness. Neuropsychopharmacology (2012) 0.82
Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective. Curr Med Chem (2012) 0.81
Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors. Bioorg Med Chem Lett (2012) 0.81
A program to reduce use of physical restraint in psychiatric inpatient facilities. Psychiatr Serv (2004) 0.81
Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam. Anal Bioanal Chem (2003) 0.81
Brain correlates of negative visuospatial priming in healthy children. Psychiatry Res (2005) 0.81
Predicted refraction versus refraction outcome in cataract surgery after trabeculectomy. J Glaucoma (2009) 0.80
Synthesis, characterization and evaluation of mannich bases as potent antifungal and hydrogen peroxide scavenging agents. Acta Pol Pharm (2012) 0.80
Conservative management of a large oesophageal haematoma as a complication of systemic thrombolysis. Heart Lung Circ (2004) 0.80
Brain activation during implicit sequence learning in individuals with trichotillomania. Psychiatry Res (2007) 0.79
Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia. Bioorg Med Chem Lett (2012) 0.78
Sequential chemoradiotherapy versus radiotherapy in the management of locally advanced non-small-cell lung cancer. Adv Ther (2003) 0.78
GLUTAMICS--a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome. J Thorac Cardiovasc Surg (2012) 0.78
Design and synthesis of protein superfamily-targeted chemical libraries for lead identification and optimization. Curr Med Chem (2005) 0.77
Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors. Eur J Med Chem (2012) 0.77
Treatment settings and metabolic monitoring for people experiencing first-episode psychosis. J Psychosoc Nurs Ment Health Serv (2010) 0.77
Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy. Med Dosim (2010) 0.77
Recent advances in the discovery of small molecule mTOR inhibitors. Future Med Chem (2010) 0.76
Assessment of post-traumatic stress disorder in veterans by videoconferencing and by face-to-face methods. J Telemed Telecare (2009) 0.76
Discovery of P3971 an orally efficacious novel anticancer agent targeting HIF-1α and STAT3 pathways. Anticancer Agents Med Chem (2013) 0.75
Exploration of pyridine containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors. Bioorg Med Chem Lett (2011) 0.75
Activated Phosphorylated STAT1 Levels as a Biologically Relevant Immune Signal in Schizophrenia. Neuroimmunomodulation (2016) 0.75
Deposition of 7-aminoclonazepam and clonazepam in hair following a single dose of Klonopin. J Anal Toxicol (2002) 0.75
Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors. Eur J Med Chem (2013) 0.75
Cracking the code: dopamine signaling in cocaine dependence. Am J Psychiatry (2011) 0.75
Riociguat as a treatment regime for pulmonary arterial hypertension: a review. Clin Exp Hypertens (2014) 0.75
Complete Heart Block due to Aortic Root Abscesses. J Assoc Physicians India (2015) 0.75
The behavioral and cognitive effects of two benzodiazepines associated with drug-facilitated sexual assault. J Forensic Sci (2002) 0.75
An ultrasensitive high-throughput electrochemiluminescence immunoassay for the Cdc42-associated protein tyrosine kinase ACK1. Anal Biochem (2007) 0.75
Isolation of Salmonella paratyphi A from a female with diabetic foot ulcer. Indian J Pathol Microbiol (2011) 0.75
Dihedral representations and statistical geometric optics. I. Spherocylindrical lenses. J Opt Soc Am A Opt Image Sci Vis (2005) 0.75
Synthesis and characterization of 3β-substituted amides of 17a-aza-D-homo- 4-androsten-17-one as potent 5α-reductase inhibitors and antimicrobial agents. Curr Top Med Chem (2013) 0.75
Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitors. Bioorg Med Chem Lett (2009) 0.75
First total synthesis of prasinic acid and its anticancer activity. Bioorg Med Chem Lett (2012) 0.75
Lead optimization of isocytosine-derived xanthine oxidase inhibitors. Bioorg Med Chem Lett (2012) 0.75
Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits. Bioorg Med Chem (2012) 0.75
Synthesis, characterization and evaluation of benzylidene analogues as a new class of potential antioxidant agents. Acta Pol Pharm (2012) 0.75